Invest in better immunocontraception with pZP vaccine

Investment Thesis

Proof of concept complete with over eight studies demonstrating fertility control in wildlife field trials
Clear development pathway
EPA approval expected by 1Q 2020
Revenue can be generated quickly
Positive ROI and ROE
Commercial-ready in one year from closing on funding means cashflow can fund life-cycle management and portfolio expansion to develop vaccines for other species without need for additional dilutive funding
For information on investing contact us

Opportunity / Unmet Need

Immunocontraception has immediate application in control of overabundant wild horse populations and urban deer.
Feral Cats
Feral Dogs
Macaques
Wild Burros
Feral Cattle
Feral Camels
Feral Hogs

Use of Proceeds and Development Plan

USE OF PROCEEDS:

Create, standardize and validate manufacturing protocol
Compile submission dossier for EPA
QA:Manufacture batches to affirm antibody response and release specs
Field testing of SpayVac immunocontraception with potential customers
Vaccination of additional overabundant species to expand usage to a greater number of species
Develop other immunocontraceptive vaccines for feral cats and feral dogs
Set up long-term production facility